Bromfenac is a non-steroidal anti-inflammatory drug (NSAID) marketed in the US as an ophthalmic solution (current brand names Prolensa and Bromday prior formulation brand name Xibrom which has since been discontinued.) by ISTA Pharmaceuticals for short-term local use. Prolensa and Bromday are the once-daily formulation of bromfenac while Xibrom was approved for twice-daily administration.
This page contains content from the copyrighted Wikipedia article "Bromfenac"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
